EMD-19166

Single-particle
3.12 Å
EMD-19166 Deposition: 14/12/2023
Map released: 19/06/2024
Last modified: 13/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-19166

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8rh2 summary report (pdf.gz) Map-8rh2 FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Trimeric HSV-2G gB ectodomain in postfusion conformation with three bound HDIT102 Fab molecules.

EMD-19166

Single-particle
3.12 Å
EMD-19166 Deposition: 14/12/2023
Map released: 19/06/2024
Last modified: 13/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Human herpesvirus 2 strain G
Sample: Trimeric HSV-2G gB ectodomain in post-fusion conformation with three bound HDIT101 Fab molecules
Fitted models: 8rh2

Deposition Authors: Kalbermatter D, Seyfizadeh N, Imhof T, Ries M, Mueller C, Jenner L, Blumenschein E, Yendrzheyevskiy A, Moog K , Eckert D, Engel R, Diebolder P, Chami M, Krauss J, Schaller T, Arndt M
Development of a highly effective combination monoclonal antibody therapy against Herpes simplex virus.
PUBMED: 38807208
DOI: doi:10.1186/s12929-024-01045-2
ISSN: 1423-0127
Grant Support: